Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2010
Isolation of circulating tumor cells using a microvortex-generating herringbone-chipShannon L Stott, Chia-Hsien Hsu, Dina I Tsukrov, et al.The New England Journal of Medicine|June 7, 2011
Improved survival with vemurafenib in melanoma with BRAF V600E mutationPaul B Chapman, Axel Hauschild, Caroline Robert, et al.The New England Journal of Medicine|February 24, 2012
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenibJeffrey A Sosman, Kevin B Kim, Lynn Schuchter, et al.European Urology|December 21, 2017
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants MeetingJun Luo, Gerhardt Attard, Steven P Balk, et al.Cancer Discovery|January 6, 2018
An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate CancerDavid T Miyamoto, Richard J Lee, Mark Kalinich, et al.The Lancet. Oncology|May 15, 2023
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysisAlexandre R Zlotta, Leslie K Ballas, Andrzej Niemierko, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanomaKerstin Trunzer, Anna C Pavlick, Lynn Schuchter, et al.Science Translational Medicine|April 5, 2013
Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cellsEmre Ozkumur, Ajay M Shah, Jordan C Ciciliano, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 17, 2013
Prostate cancer, version 1.2014James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2012
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelinesJames L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.Pageof 10